MDT

Medtronic Plc

Exchange: NYSESector: HealthcareIndustry: Medical Devices

As the global market leader, Medtronic Cranial and Spinal Technologies is transforming the standard of care in spine and cranial surgery by putting patients first and addressing the complex challenges faced by spine and neurosurgeons. With a portfolio of 150 products covering more than 20 pathologies, we serve over 4 million patients annually. Building on a legacy of innovation, our AiBLE™ ecosystem integrates advanced technologies, data, and AI with a patient-centric approach, offering customizable solutions to enhance surgical precision, improve workflow efficiency, and achieve better outcomes, before, during, and beyond surgery. About Medtronic Bold thinking. Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.

Did you know?

Free cash flow has been growing at -2.1% annually.

Current Price

$78.30

-2.13%

GoodMoat Value

$53.32

31.9% overvalued

Profile

Valuation (TTM)

Market Cap$100.38B

P/E21.76

EV$131.44B

P/B2.09

Shares Out1.28B

P/Sales2.83

Revenue$35.48B

EV/EBITDA12.87

Medtronic Plc (MDT) Company Profile

GoodMoat Analysis

Based on data as of March 26, 2026

Medtronic is a global leader in medical devices, but its investment case is mixed for a value investor. It has a moderate competitive moat and pays a stable dividend, but faces growth challenges and trades at a valuation that appears high relative to its fundamentals.

Read full analysis

Medtronic is a global healthcare technology company that designs, manufactures, and sells medical devices and therapies. Its products treat over 70 health conditions, including cardiac rhythm disorders, diabetes, spinal conditions, and neurological diseases. Its primary customers are hospitals, healthcare systems, and individual patients. The company's moat, assessed via the GoodMoat framework, stems from several factors: high switching costs for doctors trained on its systems, regulatory barriers for new device approvals, a strong brand trusted by surgeons, and strategic partnerships within healthcare. However, its moat score is likely moderate, not exceptional, as it faces intense competition and potential disruption from new technologies. Key risks (Section 5 Red Flags) include potential margin compression from pricing pressure, execution risk in integrating new innovations, and growth deceleration, as its 8.7% YoY revenue growth is solid but not high for the sector. A value investor might be interested in its 3.19% dividend yield and stable business. However, caution is warranted. The GoodMoat Target price of $53.32 suggests the current price of $87.89 may be unfavourable. Furthermore, a P/E of 24.4 and an ROE of 9.6% (below the 15-20% high-quality threshold) indicate the stock is priced for more robust performance than its current fundamentals demonstrate. The 4.6% FCF yield is adequate but not compelling for a business with moderate growth. Analysis based on data as of 2024-05-15.

MDT Company Information

With a portfolio of 150 products covering more than 20 pathologies, we serve over 4 million patients annually.

Building on a legacy of innovation, our AiBLE™ ecosystem integrates advanced technologies, data, and AI with a patient-centric approach, offering customizable solutions to enhance surgical precision, improve workflow efficiency, and achieve better outcomes, before, during, and beyond surgery.

About Medtronic Bold thinking. Bold thinking. Bolder actions. We are Medtronic.

Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions.

Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more.

Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.

Sector

Healthcare

Industry

Medical Devices

Exchange

NYSE

Country

Ireland

MDT Key Officers

Key officers data coming soon

MDT Company Profile

Medtronic Plc (MDT) is a Healthcare company in the Medical Devices industry. It trades on NYSE. The company is based in Ireland.

Market cap is $100.38B. There are 1282.0M shares outstanding. Dividend yield is 3.58%.

See the full Medtronic Plc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if MDT is a good investment.